Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients

被引：3

作者：

He, Rong ^{[1
]}

Chiou, Jonathan ^{[2
]}

Chiou, Allison ^{[3
]}

Chen, Dong ^{[1
]}

Chen, Constance P. ^{[4
]}

Spethman, Caroline ^{[5
]}

Bessonen, Kurt R. ^{[1
]}

Oliveira, Jennifer L. ^{[1
]}

Nguyen, Phuong L. ^{[1
]}

Reichard, Kaaren K. ^{[1
]}

Hoyer, James D. ^{[1
]}

Althoff, Simon D. ^{[1
]}

Roh, Dana J. ^{[1
]}

Miller, Mechelle A. ^{[1
]}

Yuan, Ji ^{[1
]}

Olteanu, Horatiu ^{[1
]}

Begna, Kebede ^{[6
]}

Tefferi, Ayalew ^{[6
]}

Alkhateeb, Hassan ^{[6
]}

Patnaik, Mrinal M. ^{[6
]}

Litzow, Mark R. ^{[6
]}

Al-Kali, Aref ^{[6
]}

Viswanatha, David S. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Div Hematopathol, Rochester, MN 55905 USA

[2] Dartmouth Coll, Hanover, NH USA

[3] Wellesley Coll, Wellesley, MA USA

[4] Univ Notre Dame, Coll Sci, Notre Dame, IN 46556 USA

[5] Univ Nebraska, Sch Med, Omaha, NE 68198 USA

[6] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA

来源：

BLOOD CANCER JOURNAL | 2022年 / 12卷 / 01期

关键词：

CLONAL HEMATOPOIESIS; MUTATIONS; MDS; RISK;

D O I：

10.1038/s41408-022-00612-w

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[31] PROGNOSTIC VALUE OF CLONAL CHROMOSOMAL-ABNORMALITIES IN PATIENTS WITH PRIMARY MYELODYSPLASTIC SYNDROMES
GYGER, M
INFANTERIVARD, C
DANGELO, G
FOREST, L
LUSSIER, P
AMERICAN JOURNAL OF HEMATOLOGY, 1988, 28 (01) : 13 - 20
[32] Prognostic evaluation of the microvascular network in myelodysplastic syndromes
P Korkolopoulou
E Apostolidou
PM Pavlopoulos
N Kavantzas
N Vyniou
I Thymara
E Terpos
E Patsouris
X Yataganas
P Davaris
Leukemia, 2001, 15 : 1369 - 1376
[33] Prognostic evaluation of the microvascular network in myelodysplastic syndromes
Korkolopoulou, P
Apostolidou, E
Pavlopoulos, PM
Kavantzas, N
Vyniou, N
Thymara, I
Terpos, E
Patsouris, E
Yataganas, X
Davaris, P
LEUKEMIA, 2001, 15 (09) : 1369 - 1376
[34] Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes
Shimazaki, K
Ohshima, K
Suzumiya, J
Kawasaki, C
Kikuchi, M
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) : 584 - 590
[35] Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes
Wimazal, F
Sperr, WR
Kundi, M
Meidlinger, P
Fonatsch, C
Jordan, JH
Thalhammer-Scherrer, R
Schwarzinger, I
Geissler, K
Lechner, K
Valent, P
LEUKEMIA RESEARCH, 2001, 25 (04) : 287 - 294
[36] PROGNOSTIC VALUE OF THE FAB CLASSIFICATION FOR MYELODYSPLASTIC SYNDROMES (MDS)
AUL, C
FISCHER, JT
HORSTKOTTE, D
SCHNEIDER, W
BLUT, 1984, 49 (03): : 246 - 246
[37] Novel cytogenetic markers with prognostic relevance in myelodysplastic syndromes (MDS): A study on 491 patients
Bernasconi, P.
Mersy, C.
Boni, M.
Cavigliano, P. M.
Calatroni, S.
Giardini, I
Rocca, B.
Zappatore, R.
Caresana, M.
Dambruoso, I
Astori, C.
Lazzarino, M.
Bernasconi, C.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 37 - 37
[38] Evaluation of VEGF and VEGFR gene expression as prognostic markers in low and intermediate-1 risk patients with myelodysplastic syndromes
Kalitin, Nikolay
Dudina, Galina
Kostritsa, Natalia
Sivirinova, Anastasiya
Karamysheva, Aida
ONCOLOGY LETTERS, 2023, 25 (03)
[39] Update on genetic and molecular markers associated with myelodysplastic syndromes
Valent, Peter
Wieser, Rotraud
LEUKEMIA & LYMPHOMA, 2009, 50 (03) : 341 - 348
[40] Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact
Oelschlaegel, Uta
Oelschlaeger, Lorenz
von Bonin, Malte
Kramer, Michael
Sockel, Katja
Mohr, Brigitte
Wagenfuehr, Lisa
Kroschinsky, Frank
Bornhaeuser, Martin
Platzbecker, Uwe
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (02) : 141 - 150

← 1 2 3 4 5 →